Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion type Assertion NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_head.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion description "[Serum gastrin concentrations and gastric corpus and tumour histidine decarboxylase mRNA abundances were assessed in patients with type-1 gastric NETs before and 72 h after the administration of 25 �g/h intravenous octreotide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_provenance.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion evidence source_evidence_literature NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_provenance.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion SIO_000772 23249603 NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_provenance.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion wasDerivedFrom befree-20140225 NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_provenance.
- NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_assertion wasGeneratedBy ECO_0000203 NP505268.RA6AlCJJyplTULNzJKeZj8M1nWK7SoUI8OpvDbc1aT0ys130_provenance.